Literature DB >> 20451577

Identification and consequences of galectin-3 expression in pituitary tumors.

A Righi1, L Jin, S Zhang, G Stilling, B W Scheithauer, K Kovacs, R V Lloyd.   

Abstract

Although the mechanisms regulating pituitary tumor development and progression are still unclear, new information on the molecular mechanisms involved in the pathogenesis of human pituitary tumors have accumulated. Recent evidence suggests that galectin-3 plays an important role in pituitary tumorigenesis and in tumor progression. Galectin-3 is expressed in a variety of tumors and the intensity of expression and localization depend on tumor progression, invasiveness and metastatic potential. Galectin-3 expression has been used as a potential diagnostic and/or prognostic marker in a variety of neoplasms. This review summarizes existing information regarding the structural and functional properties of galectin-3 protein as well as the LGALS3 gene in pituitary tumorigenesis. Given its role in pituitary tumor cell proliferation and in apoptosis, galectin-3 may be a target for the treatment of aggressive pituitary tumors. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20451577     DOI: 10.1016/j.mce.2010.04.026

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  7 in total

1.  The expressions and clinical significances of tissue and serum galectin-3 in pancreatic carcinoma.

Authors:  Ling Xie; Wen-Kai Ni; Xu-Dong Chen; Ming-Bing Xiao; Bu-You Chen; Song He; Cui-Hua Lu; Xiao-Yan Li; Feng Jiang; Run-Zhou Ni
Journal:  J Cancer Res Clin Oncol       Date:  2012-02-25       Impact factor: 4.553

2.  The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3.

Authors:  Alberto Righi; Marco Faustini-Fustini; Luca Morandi; Valentina Monti; Sofia Asioli; Diego Mazzatenta; Antonella Bacci; Maria Pia Foschini
Journal:  Endocrine       Date:  2016-08-04       Impact factor: 3.633

Review 3.  Genetic and Epigenetic Causes of Pituitary Adenomas.

Authors:  Mengqi Chang; Chengxian Yang; Xinjie Bao; Renzhi Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-26       Impact factor: 5.555

4.  Serum galectin-3 as a potential marker for gastric cancer.

Authors:  Daye Cheng; Bin Liang; Yunhui Li
Journal:  Med Sci Monit       Date:  2015-03-13

Review 5.  Animal models of pituitary neoplasia.

Authors:  K E Lines; M Stevenson; R V Thakker
Journal:  Mol Cell Endocrinol       Date:  2015-08-28       Impact factor: 4.102

6.  The role of galectin-3 in the tumorigenesis and progression of pituitary tumors.

Authors:  Bo Diao; Ying Liu; Guo-Zheng Xu; Yi Zhang; Jun Xie; Jie Gong
Journal:  Oncol Lett       Date:  2018-02-02       Impact factor: 2.967

7.  Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study.

Authors:  Chiara Bima; Sabrina Chiloiro; Antonella Giampietro; Marco Gessi; Pier Paolo Mattogno; Liverana Lauretti; Carmelo Anile; Guido Rindi; Alfredo Pontecorvi; Laura De Marinis; Antonio Bianchi
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-12       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.